Direct Answer
A professional skincare capsules RFQ checklist should define the intended formula, capsule shell, unit fill weight, mold geometry, primary packaging, stability protocol, regulatory market, and shipment conditions before samples are requested. Otherwise, the buyer may approve an attractive laboratory capsule that cannot be reproduced at commercial scale or remain stable through global distribution.
For spa and professional programs, the RFQ should also specify treatment protocol, expected opening method, single-use dosage, storage environment, and whether operators will handle capsules with wet or gloved hands. Ask the serum capsules manufacturer to produce samples using production-intent ingredients, shell composition, tooling, and packaging rather than substitute materials. Require proposed specifications for fill-weight variation, seam integrity, leakage, oxidation, microbial limits, and shelf life. The objective is not merely to obtain samples quickly; it is to ensure that sampling generates decision-grade evidence for procurement, R&D, QA, regulatory, and launch teams.
Key Takeaways for Private Label Buyers
- Freeze the target active system, fill viscosity, fragrance, color, and claims before comparing samples.
- Identify the exact shell material, plasticizer system, animal origin, allergen status, and vegan or halal requirements.
- Request production-intent fill weight, mold geometry, seam design, and opening performance.
- Evaluate jar, blister, pouch, and secondary-carton compatibility under realistic heat, humidity, light, and transport conditions.
- Define stability endpoints and acceptance criteria before sampling, not after formula approval.
- Connect sample approval to labeling documents, scale-up evidence, reserved capacity, and the intended launch calendar.
Buyer Context
Serum capsules are a combined formulation, shell-conversion, filling, and packaging system. A change in one component can alter the performance of the entire SKU. This distinguishes capsule sourcing from conventional bottled serum procurement and makes a superficial sample review an inadequate basis for supplier qualification.
The risks vary by format. Retinol capsules require disciplined control of oxygen, light, ingredient purity, and active assay. Facial oil and hair oil capsules must manage rancidity, fragrance migration, and shell softening. Eye serum capsules require precise unit dosing and comfortable opening force. Cleansing oil capsules may contain surfactants that interact with the shell or seam. Vegan systems based on modified starch, carrageenan, or other non-gelatin materials may respond differently to heat and humidity.
This issue becomes material when an incumbent supplier experiences a quality event or capacity interruption, or when a brand enters softgel skincare without an internally qualified line. A prospective cosmetic softgel capsule factory should therefore be assessed as a resilience node, not simply as a source of samples. Procurement should examine line segregation, raw-material continuity, backup tooling, batch traceability, labor controls, environmental records, business continuity, and intellectual-property governance.
Commercial positioning should remain evidence-led. Mintel global beauty market reports can inform category and format assumptions, but market data does not replace formula feasibility. Likewise, claims and label planning should be checked against applicable FDA cosmetics guidance documents. FDA alignment should not be interpreted as product approval.
PZIK states that it supports ISO 22716 pilot runs from 1,000 units, targets a formulation-to-shelf cycle of under 30 days, and can scale beyond 500,000 units per SKU without formulation transfer. A mature buyer should convert each statement into an auditable RFQ requirement: named equipment, demonstrated batch history, validated production ranges, capacity reservation terms, deviation controls, and confirmation that the approved sample remains the production formula.
Capsule Formula, Shell, Mold, and Packaging Factors
Fill Formula and Oxidation Control
Start with a quantitative formula brief rather than a list of preferred ingredients. State the active concentration, carrier oils, antioxidants, colorants, fragrance, excluded substances, target sensory profile, and claim boundaries. Ask the ODM to disclose whether the fill is anhydrous, its viscosity range at filling temperature, and any known interaction with the shell. Water, solvents, surfactants, essential oils, and highly mobile ingredients can affect seam strength, tackiness, or brittleness.
For encapsulated retinol skincare, require active assay at release and throughout stability, together with controls for oxygen exposure, light, raw-material age, and headspace. If salicylic acid is being considered in a capsule formula, the safety assessment and intended use should be reviewed against sources such as the CIR final report on salicylic acid in cosmetics and the regulations of each destination market.
Shell, Fill Weight, and Mold
The shell specification should identify gelatin species or vegan polymer, plasticizers, pigments, opacifiers, preservatives, processing aids, and origin documentation. Vegan status alone does not establish humidity resistance, opening performance, or compatibility with the serum. Halal programs should define the required certifier and mutual-recognition pathway; the MUI World Halal Council mutual-recognition guide is one useful qualification reference.
Fill weight is both a claims and manufacturing control. Buyers should request the nominal weight, proposed tolerance, in-process sampling method, rejection rules, and measurement-system capability. Custom molds should be reviewed for cavity volume, twist-off or cut-open geometry, edge comfort, tooling ownership, maintenance responsibility, replacement lead time, and transfer rights. Existing skincare capsule product lines may shorten qualification, while custom geometry increases tooling and validation dependencies.
Packaging, Storage, and Stability
Do not approve a loose capsule independently from its final package. Jars may expose multiple units to repeated oxygen, humidity, and handling, while blisters provide stronger unit separation but require lidding, cavity, seal, and opening validation. Pouches can create compression and abrasion risks. Packaging studies should evaluate leakage, shell adhesion, deformation, odor transfer, color change, active degradation, and consumer opening performance.
The stability plan should reflect commercial routes, including elevated heat and humidity, light exposure where relevant, temperature cycling, vibration, compression, and real-time storage. Test both bulk capsules and finished cosmetic softgel products. Shipment specifications should address maximum exposure conditions, pallet configuration, container protection, and data-logger use for high-risk lanes.
Decision Framework Table
The following framework can be used to compare a prospective serum capsule supplier with approved internal specifications and incumbent capability.
| Factor | What to Check | Why It Matters | ODM Buyer Note |
|---|---|---|---|
| Program scope | Markets, treatment protocol, claims, volume, and launch date | Determines compliance, testing, and capacity requirements | Issue one controlled brief to all bidders |
| Fill formula | Active level, viscosity, oxidation sensitivity, and shell interaction | Controls filling behavior and shelf-life risk | Reject undisclosed sampling substitutions |
| Shell system | Material, plasticizer, origin, allergens, and certification | Affects stability, ESG review, and market access | Request the complete specification and change-control process |
| Fill weight | Nominal value, tolerance, sampling plan, and capability data | Protects dosing consistency and label accuracy | Review actual batch distribution, not averages alone |
| Mold | Geometry, opening method, ownership, maintenance, and backup | Influences usability and continuity of supply | Define tooling transfer rights contractually |
| Packaging | Jar, blister, pouch, closure, seal, and secondary protection | Controls moisture, oxygen, abrasion, and leakage exposure | Sample in the intended commercial pack |
| Stability | Methods, conditions, endpoints, acceptance criteria, and reporting | Supports shelf life and distribution decisions | Approve the protocol before testing begins |
| Scale-up | Production equipment, batch range, line controls, and reserved capacity | Reduces sample-to-production divergence | Link the golden sample to the master manufacturing record |
A broader review of serum capsule products can help procurement standardize comparison criteria across retinol, eye, facial oil, cleansing oil, and hair oil programs. However, each SKU still requires its own compatibility and stability evidence.
ODM Manufacturing Considerations
A professional skincare capsules RFQ checklist should define what the supplier must prove before samples are requested. This prevents a visually appealing prototype from being mistaken for a manufacturing-ready specification. The RFQ should state the intended capsule type, target market, formula restrictions, package format, annual volume range, and expected launch schedule.
Sample confirmation: Request a written sampling plan showing the number of variants, units per variant, evaluation criteria, and revision rounds. Confirmation should cover appearance, odor, skin feel, capsule opening behavior, unit mass, and serum discharge. Record the approved sample code, formula revision, shell color, dimensions, and package components so later changes are traceable.
Formula and shell customization: Provide prohibited ingredients, target claims, fragrance limits, allergen requirements, and regional restrictions. The supplier should disclose the intended rheology range and whether suspended ingredients can remain uniform during storage. Shell choices may include gelatin-based or plant-derived systems. Compare shell composition, moisture sensitivity, color consistency, seam quality, and interaction with retinol, facial oil, eye serum, cleansing oil, or hair oil fills. Buyers considering plant-derived formats can review typical vegan skincare capsule options before finalizing the RFQ.
Mold and packaging selection: Standard shapes generally shorten development, while distinctive molds require closer review of seam geometry, ejection performance, dose capacity, and tooling availability. Specify nominal fill weight and acceptable unit variation. For jars, evaluate closure liner, headspace, capsule movement, and moisture exposure after opening. For blister formats, confirm pocket depth, sealing material, opening force, and whether the capsule is compressed during sealing or distribution.
Stability, MOQ, and documentation: Ask for a study protocol tied to expected climate zones and package configuration. Track shell hardness, tackiness, color, odor, mass change, serum uniformity, and active-content trend where relevant. MOQ should be separated by formula batch, shell color, mold, decoration, and finished package rather than presented as one number. Labeling files should include the ingredient declaration, net-content basis, warnings, responsible-party details, batch coding method, shelf-life support, and claim substantiation. The FDA cosmetics guidance documents are a useful reference for US-market responsibilities. For halal positioning, verify the current certification and recognition route using information from the MUI World Halal Council.
Shipment conditions: State acceptable transit temperature, maximum route duration, carton orientation, pallet configuration, and data-logger requirements. Define who reviews excursions and what evidence is required before affected capsules may be released. This becomes especially important when qualifying an alternate supplier after an incumbent factory suffers a major quality incident, strike, or capacity interruption. Procurement teams facing corporate carbon targets should also request route-level freight data and supplier emissions records during qualification.
Common Problems or Failure Cases
- Shell brittleness: Capsules crack during handling when shell moisture falls outside its functional range or when the formulation extracts plasticizing components. Inspect breakage after conditioned storage, not only immediately after production.
- Sticking and deformation: High humidity, unsuitable jar materials, or excessive stacking pressure can make capsules adhere to one another or lose shape. Check dispensing after repeated package opening under expected spa conditions.
- Fill separation: Oils, dispersions, pigments, or suspended actives may stratify during storage. Compare samples from the beginning, middle, and end of the batch and inspect capsules after temperature cycling.
- Leakage: Inadequate seam formation, incompatible fill chemistry, excessive dose, or rough downstream handling can create slow seepage. Examine individual cavities and the inside of the package for oil transfer.
- Fragrance sensitivity: Some fragrance components can migrate into or soften a capsule shell. A fragrance-free benchmark helps determine whether the perfume system is causing odor drift, surface tack, or weakening.
- Package deformation: Heat can distort blister pockets, liners, or lightweight jars even when the capsules remain intact. Evaluate the filled retail pack rather than relying solely on empty-component specifications.
Supplier Checklist
Use the following questions to compare an OEM/ODM capsule manufacturer on evidence rather than presentation quality:
- Is the complete shell composition disclosed, including colorants and processing aids?
- What fill rheology range can the dosing equipment control consistently?
- What are the nominal unit mass, acceptance limits, sampling frequency, and rejection rules?
- How are seam defects, pinholes, surface oil, and damaged capsules identified?
- What measures protect oxygen-sensitive serum ingredients during compounding, encapsulation, and packing?
- Which mold shapes and dose capacities are currently qualified for the proposed formula?
- Will studies use the exact jar, blister, liner, and closure intended for launch?
- Are heat, humidity, light exposure, and post-opening conditions included in the study plan?
- What are the separate MOQs and lead times for formula, shell, mold, and packaging changes?
- Which documents accompany each lot, and how are label revisions and ingredient substitutions approved?
- What transit limits, logger rules, quarantine steps, and excursion decisions apply to shipments?
- Can the supplier provide traceable records for complaints, corrective actions, and batch disposition?
FAQ
Can a factory guarantee that our core serum formula will never be leaked?
No credible supplier can promise absolute protection. Verify role-based system access, segmented formula files, download logs, restricted laboratory access, visitor controls, confidentiality terms, employee exit procedures, and rules governing retained samples. The contract should define ownership, permitted use, breach notification, and remedies.
How can we secure priority supply during a global ingredient shortage?
Do not rely on a verbal priority promise. Request forecast commitments, reserved-capacity terms, safety-stock ownership, allocation rules, approved secondary sources, and notification deadlines. Any substitute ingredient should require written buyer approval and a documented assessment of formula, shell, claims, and stability effects.
What insurance should cover a major capsule quality complaint?
Request current certificates for product liability and, where applicable, product recall coverage. Review policy limits, geographic scope, exclusions, deductibles, insurer rating, and whether defense expenses reduce the limit. Confirm that capsule leakage, contamination, labeling errors, and cross-border claims are not silently excluded.
How many samples should be approved before placing a manufacturing order?
Approve enough units to assess appearance, opening, application, package dispensing, and short-term conditioning across each formula, shell color, mold, and package combination. A single presentation sample is insufficient when several variables change simultaneously.
Can one stability study support every sales market?
Not automatically. Climate, shipping route, label rules, retail package, and intended shelf life may differ. Ask the supplier to justify the protocol against each target market and identify where additional real-time or package-specific evidence is needed.
Does the FDA approve cosmetic serum capsules before launch?
Generally, cosmetic products are not individually preapproved by the FDA, although color additives have separate requirements. The responsible company remains accountable for safety, labeling, records, and legally compliant claims. Regulatory review should be completed before artwork release.
Should a buyer test both jar and blister presentations?
Yes, if both may be commercialized. The formats expose capsules to different moisture, pressure, opening, and handling conditions. Results from one package should not be assumed to represent the other without supporting evidence.